Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and T-cell engagers.
The first cell rejuvenation therapy is set to enter clinics, testing if aging cells can be reset to a younger, healthier ...
Learn about Carbios' story, as the French biotech focused on recycling polyethylene terephthalate (PET), faces pressure after ...
Meet 5 hot biotechs in Arizona, from Phoenix to Tucson, that have raised significant funding over the past decade.
February 2026 saw a major biopharma acquisition, four key buyouts, and licensing deals in antibodies, small molecules, and ...
Delve into the field of pulmonary hypertension as GSK places a $950M bet on 35Pharma's candidate HS235 following the footsteps of Winrevair.
The companies Vaxcyte, Generate Biomedicines, and Immunic bagged the biggest biotech funding rounds overall in February 2026.
Cambridge Symposium: Novel Approaches in Translational Oncology – 26th March, 2026 Join industry and academic leaders in Cambridge for Champions Oncology’s UK Symposium, a one‑day, in‑person event ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results